Rocket Lab USA, Inc. · RKLB · FY2026 Q2 · Calendar Q3 2026
Rocket Lab: Demand Is Strong, Execution Risks Remain Central
Rocket Lab's demand backdrop and backlog support a constructive growth case, but the next phase depends on executing Neutron, integrating Iridium, and controlling capital intensity.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about RKLB FY2026 Q2
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
The current analysis adds the pending Iridium acquisition, GHOST deployable launch pads, a first GEO satellite contract, and the Flatellite spacecraft to the prior-quarter growth plan.
Guidance delta
Guidance sentiment was maintained in the supplied analysis; no new numerical guidance change was identified.
Key takeaways
- The supplied analysis describes record Q2 revenue and a $2.36 billion backlog as evidence of demand across launch and Space Systems.
- Neutron is targeted for first flight in Q4 2026, while GHOST pads and the pending Iridium acquisition broaden the growth plan.
- The main investor test is whether Rocket Lab can scale launches while managing integration, capital intensity, and cash burn.
Management priorities
- Advance Neutron toward its targeted Q4 2026 first flight and build launch cadence
- Expand GHOST deployable launch capability and Rocket Lab Germany
- Broaden satellite-component production and integrate the pending Iridium transaction
Follow RKLB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 6, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citizens | Market Outperform | Market Outperform | Maintain | Oct 16, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 15, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 15, 2026 |
| B of A Securities | Buy | Buy | Maintain | Aug 31, 2026 |
| KGI Securities | Outperform | Neutral | Upgrade | Jul 27, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jun 30, 2026 |
| Needham | Buy | Buy | Maintain | Jun 30, 2026 |
| Craig-Hallum | Buy | Buy | Maintain | Jun 30, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | May 12, 2026 |
| BTIG | Hold | Hold | Maintain | May 12, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 20, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 20, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jan 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 8, 2025 |
| Citizens Capital Markets | Market Perform | Market Perform | Maintain | Mar 14, 2025 |
| Roth MKM | Buy | Buy | Maintain | Jun 18, 2024 |
| Credit Suisse | Underperform | Underperform | Maintain | Oct 12, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Aug 31, 2022 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 9, 2021 |
Named analyst price targets
Upside is calculated against the persisted current price $51.04. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Needham | Ryan Koontz | $120 | $55.25 | +135.1% | Oct 16, 2026 |
| KeyBanc | Analyst unavailable | $100 | $59.18 | +95.9% | Oct 15, 2026 |
| Barclays | Analyst unavailable | $85 | $68.4 | +66.6% | Oct 8, 2026 |
| Raymond James | Brian Gesuale | $80 | $61.96 | +56.8% | Sep 11, 2026 |
| Berenberg Bank | Analyst unavailable | $83 | $62.54 | +62.6% | Sep 2, 2026 |
| Cantor Fitzgerald | Andres Sheppard | $122 | $78.85 | +139.1% | Aug 11, 2026 |
| Roth Capital | Analyst unavailable | $110 | $80.04 | +115.5% | Aug 11, 2026 |
| KGI Securities | Analyst unavailable | $107 | $63.91 | +109.7% | Jul 27, 2026 |
| Piper Sandler | Alexander Potter | $83 | $76.2 | +62.6% | Jul 15, 2026 |
| Roth Capital | Suji Desilva | $130 | $98.01 | +154.7% | Jun 29, 2026 |
| Craig-Hallum | Jeff Van Rhee | $120 | $98.1 | +135.1% | Jun 29, 2026 |
| KeyBanc | Michael Leshock | $135 | $102.39 | +164.5% | Jun 15, 2026 |
| KGI Securities | Analyst unavailable | $105 | $105.05 | +105.7% | Jun 11, 2026 |
| Stifel Nicolaus | Erik Rasmussen | $132 | $114.7 | +158.6% | Jun 4, 2026 |
| Deutsche Bank | Analyst unavailable | $120 | $116.16 | +135.1% | May 12, 2026 |
| Craig-Hallum | Analyst unavailable | $98 | $78.58 | +92.0% | May 8, 2026 |
| Stifel Nicolaus | Analyst unavailable | $105 | $87.75 | +105.7% | Apr 20, 2026 |
| Roth Capital | Analyst unavailable | $100 | $82.93 | +95.9% | Apr 17, 2026 |
| Cantor Fitzgerald | Andres Sheppard | $85 | $68.37 | +66.6% | Mar 13, 2026 |
| Goldman Sachs | Anthony Valentini | $69 | $96.3 | +35.2% | Jan 20, 2026 |
| Morgan Stanley | Kristine Liwag | $105 | $90.76 | +105.7% | Jan 16, 2026 |
| Needham | Ryan Koontz | $90 | $77.55 | +76.3% | Dec 23, 2025 |
| Stifel Nicolaus | Analyst unavailable | $85 | $70.52 | +66.6% | Dec 22, 2025 |
| Needham | Ryan Koontz | $63 | $54.98 | +23.4% | Nov 12, 2025 |
| Roth Capital | Suji Desilva | $75 | $51.9 | +47.0% | Nov 11, 2025 |
| Stifel Nicolaus | Erik Rasmussen | $75 | $51.9 | +47.0% | Nov 11, 2025 |
| KeyBanc | Analyst unavailable | $75 | $67 | +47.0% | Oct 17, 2025 |
| Robert W. Baird | Peter Arment | $83 | $69.27 | +62.6% | Oct 15, 2025 |
| Cantor Fitzgerald | Andres Sheppard | $35 | $42.34 | -31.4% | Jul 14, 2025 |
| Stifel Nicolaus | Erik Rasmussen | $31 | $27.95 | -39.3% | Jan 8, 2025 |
| KeyBanc | Mike Leschock | $12 | $10.91 | -76.5% | Oct 23, 2024 |
| KeyBanc | Mike Leschock | $11 | $8.69 | -78.4% | Sep 27, 2024 |
| Morgan Stanley | Kristine Liwag | $6 | $5.65 | -88.2% | Jul 15, 2024 |
| Goldman Sachs | Noah Poponak | $4.5 | $4.56 | -91.2% | Jun 11, 2024 |
| Stifel Nicolaus | Erik Rasmussen | $9 | $3.76 | -82.4% | May 7, 2024 |
| Citigroup | Jason Gursky | $6 | $4.66 | -88.2% | Feb 12, 2024 |
| KeyBanc | Michael Leshock | $8 | $4.92 | -84.3% | Jan 17, 2024 |
| Stifel Nicolaus | Erik Rasmussen | $10 | $4.3 | -80.4% | Sep 27, 2023 |
| Deutsche Bank | Analyst unavailable | $12 | $5.36 | -76.5% | Nov 14, 2022 |
| Morgan Stanley | Analyst unavailable | $10 | $5.63 | -80.4% | Nov 11, 2022 |
| Cowen & Co. | Sam Boughedda | $8 | $5.52 | -84.3% | Aug 31, 2022 |
| Stifel Nicolaus | Analyst unavailable | $15 | $5.99 | -70.6% | Aug 17, 2022 |
| Deutsche Bank | Analyst unavailable | $15 | $6.94 | -70.6% | Aug 15, 2022 |
| Wells Fargo | Matthew Akers | $5 | $4.2 | -90.2% | Jun 21, 2022 |
| Deutsche Bank | Analyst unavailable | $14 | $5.66 | -72.6% | May 17, 2022 |
Track every rating change on RKLB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHeadquartered in Long Beach, California, Rocket Lab USA, Inc. is a prominent aerospace firm established in 2006. This company delivers a comprehensive suite of space-related services and hardware, primarily catering to the space and defense industries. Their operations encompass orbital launch capabilities, advanced spacecraft engineering and construction, production of various spacecraft components, and sophisticated on-orbit management services, including full constellation management. Rocket Lab is known for developing and producing a range of launch vehicles, from small to medium-class rockets.…
Historical context
All RKLB earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| UHAL U-Haul Holding Company | FY2027 Q2 · Calendar Q4 2026 | -15.4% | -3.2% | U-Haul Q2: Rental and storage growth, with execution risks |
| PH Parker-Hannifin Corporation | FY2027 Q1 · Calendar Q4 2026 | +8.4% | -2.0% | Parker-Hannifin lifts FY2027 outlook as broad demand and backlog strengthen |
| ITT ITT Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.7% | -2.5% | ITT Raises 2026 Outlook as Orders and Margins Strengthen |
| CMI Cummins Inc. | FY2026 Q3 · Calendar Q4 2026 | -6.0% | -4.9% | Data-center power demand supports Cummins, while outlook moderates |
| AXON Axon Enterprise, Inc. | FY2026 Q3 · Calendar Q4 2026 | -9.0% | -9.8% | Axon’s Q3 growth story meets investment, timing and margin questions |
Latest beats and misses
Who reports nextBeat on EPS
- FNFFY2026 Q3 · November 5, 20260.0% EPS+6.6% move
- MTDFY2026 Q3 · November 5, 2026+3.6% EPS+4.8% move
- IAGFY2026 Q3 · November 5, 2026+16.7% EPS+4.6% move
- GMABFY2026 Q3 · November 5, 2026+55.6% EPS-4.3% move
- STEFY2027 Q2 · November 4, 2026+9.7% EPS+2.5% move
- IRMFY2026 Q3 · November 5, 2026+4.6% EPS-11.1% move
Missed on EPS
- WPMFY2026 Q3 · November 5, 2026-1.1% EPS+2.2% move
- CPTFY2026 Q3 · November 5, 2026-27.2% EPS-3.1% move
- VMRKFY2026 Q3 · November 4, 2026-425.6% EPS+2.4% move
- NTRAFY2026 Q3 · November 5, 2026-49.3% EPS-15.2% move
- TIGOFY2026 Q3 · November 5, 2026-40.8% EPS+2.6% move
- UHALFY2027 Q2 · November 4, 2026-15.4% EPS-3.2% move
Get the RKLB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-11T14:16:25.741538+00:00
- FN2 earnings calendar · 2026-09-15T01:23:15.305287+00:00
- Polygon adjusted daily market bars · 2026-09-21T20:20:49.924236+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T20:20:49.921293+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-21. For educational purposes only; not investment advice.